Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
28
GRCE Quote, Financials, Valuation and Earnings
Last price:
$2.37
Seasonality move
:
-1.52%
Day range:
$2.16 - $2.29
52-week range:
$2.07 - $4.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.60x
Volume:
33.4K
Avg. volume:
91.3K
1-year change:
-32.25%
Market cap:
$31.4M
Revenue:
--
EPS (TTM):
-$1.54
Grace Therapeutics Number of Institutional Trades
Grace Therapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$29.7M
(Last 6 Months)
Current Institutional Ownership Percentage
20.51%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$3.1M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Grace Therapeutics Institutional Ownership
-
What Percentage Of GRCE Is Owned by Institutions?
20.51% of GRCE is owned by institutions.
-
How Many Institutions Own GRCE Shares?
Grace Therapeutics stock is owned by 18 institutional shareholders at this time.
-
Have Institutions Been Buying GRCE Stock?
Yes, institutions have bought 6.1M shares of GRCE in the last quarter.
-
Have Institutions Been Selling GRCE Stock?
Yes, institutions have sold 716.9K shares of GRCE over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
